GlaxoSmithKline (GSK.L) 18-02-20
Will GlaxoSmithKline (GSK.L) shares break below the 1650p support, or return to highs of 1846p (+11%)?
- Currently close to the 1650p support at 1657.6p (at time of writing).
- This has been identified for ostensibly strong support level. Traders should consider whetehr they think it will hold up again.
- Will the price bounce again to recent highs at 1846p? (+11%).
- Technical traders should consider potential news and developments. Check our website and the press for updates in future.
- Shares -10% from 12-month highs; +10% from 12 month lows.
Latest News
08:30: Liberum Capital reiterates its hold rating on GlaxoSmithKline (GSK) and reduced the target price to 1840p (from 1930p).
13 Feb: Societe Generale reiterates its buy rating on GlaxoSmithKline (GSK) and reduced the target price to 2240p (from 2300p).
13 Feb: HSBC reiterates its buy rating on GlaxoSmithKline (GSK) and reduced the target price to 2050p (from 2110p).
11 Feb: UBS reiterates its buy rating on GlaxoSmithKline (GSK) and reduced the target price to 1900p (from 1950p).
11 Feb: JP Morgan Cazenove reiterates its neutral rating on GlaxoSmithKline (GSK) and reduced the target price to 1750p (from 1900p).
10 Feb: Deutsche Bank reiterates its hold rating on GlaxoSmithKline (GSK) and reduced the target price to 1600p (from 1650p).
07 Feb: Barclays Capital reiterates its underweight rating on GlaxoSmithKline (GSK) and reduced the target price to 1550p (from 1650p).
Source: Bloomberg, Reuters, Alpha Terminal, FT, DJ Newswires